Civic AI
Procurement intelligence
Federal contract award
TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.
CRESTONE, INC. · Department of Health and Human Services
- Value
- $31,943,633
- Start
- Sep 9, 2019
- End
- Jan 31, 2027
- Action date
- May 18, 2026
- PIID
- 75N93019C00056
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- BOULDER, CO
- Award type
- DEFINITIVE CONTRACT
Description
TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.
Need modifications, related awards, and vendor peers? Open the full award workspace.